orthobiologics
-
Biologics
Orthobiologics Market Worth 6.06 Billion USD by 2022
PUNE, India, September 27, 2017 /PRNewswire/ — According to a new market research report “Orthobiologics Market by Product (Viscosupplementation, Synthetic Orthobiologics, DBM, BMP,…
Read More » -
Biologics
Orthobiologics Market to Reach $10.2 Billion by 2025
DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Orthobiologics Market 2014 – 2025” report to their offering. The…
Read More » -
Biologics
Kuros Acquires Xpand to Form Orthobiologics Firm with Bone Graft Substitute
December 19, 2016 Kuros Biosciences is to acquire Xpand Biotechnology by way of a share-swapping deal structured as an exchange…
Read More » -
Biologics
Biomatlante invests in innovative solutions for active healing through orthobiologics
NANTES, FRANCE (PRWEB) DECEMBER 09, 2016 Coordinated by INSERM (Institut National de la Santé et de la Recherche Médicale) and…
Read More » -
Biologics
Orthobiologics: A New Era for Articular Cartilage Surgery?
Bert R. Mandelbaum, MD, DHL (Hon) Osteochondral Autograft and Particulate Autograft Another approach to repairing smaller cartilage defects is osteochondral…
Read More » -
Biologics
Bioventus Launches SUPARTX FX™ Now with Expanded Safety Label for Repeat Injection Cycles in Knee Osteoarthritis
Bioventus Launches SUPARTZ FX™Now with Expanded Safety Label for Repeat Injection Cycles in Knee Osteoarthritis DURHAM, NC – October 12,…
Read More » -
Biologics
CollPlant Executes Non-binding Term Sheet to Develop and Commercialize a Novel Product for Spinal Fusion and Trauma Indications in Collaboration with Leading US Partner
CollPlant (TASE:CLPT), a regenerative medicine company utilizing its proprietary plant-based rhCollagen technology for tissue repair products, announced today that it has signed…
Read More »